We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$819M
AUM Growth
+$28.3M
Cap. Flow
+$39.9M
Cap. Flow %
4.88%
Top 10 Hldgs %
73.47%
Holding
2,597
New
508
Increased
1,194
Reduced
436
Closed
123

Sector Composition

Rank Sector Weight
1 Technology 5.03%
2 Healthcare 3.05%
3 Consumer Staples 2.87%
4 Financials 2.11%
5 Consumer Discretionary 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USCB icon
2376
USCB Financial Holdings
USCB
$415M
$19 ﹤0.01%
1
BANC icon
2377
Banc of California
BANC
$3.09B
$18 ﹤0.01%
+1
New +$19
ESCA icon
2378
Escalade
ESCA
$286M
$18 ﹤0.01%
1
HYLN icon
2379
Hyliion Holdings
HYLN
$699M
$18 ﹤0.01%
10
NPWR icon
2380
NET Power
NPWR
$143M
$18 ﹤0.01%
11
-516
-98% -$1.1K
SMTI icon
2381
Sanara MedTech
SMTI
$316M
$18 ﹤0.01%
+1
New +$21
UPB
2382
Upstream Bio Inc
UPB
$386M
$18 ﹤0.01%
+2
New +$36
ONTF
2383
DELISTED
ON24
ONTF
$17 ﹤0.01%
+2
New +$16
TITN icon
2384
Titan Machinery
TITN
$438M
$17 ﹤0.01%
+1
New +$17
CTEV
2385
Claritev Corp
CTEV
$592M
$17 ﹤0.01%
+1
New +$22
ARCT icon
2386
Arcturus Therapeutics
ARCT
$214M
$16 ﹤0.01%
+2
New +$15
DCGO icon
2387
DocGo
DCGO
$57.4M
$16 ﹤0.01%
+25
New +$19
GWRS icon
2388
Global Water Resources
GWRS
$219M
$16 ﹤0.01%
+2
New +$17
HLLY icon
2389
Holley
HLLY
$378M
$16 ﹤0.01%
+5
New +$19
IKT icon
2390
Inhibikase Therapeutics
IKT
$385M
$16 ﹤0.01%
+9
New +$16
KLTR icon
2391
Kaltura
KLTR
$249M
$16 ﹤0.01%
13
+10
+333% +$14
RMR icon
2392
The RMR Group
RMR
$337M
$16 ﹤0.01%
1
TG icon
2393
Tredegar Corp
TG
$275M
$16 ﹤0.01%
+2
New +$17
AIRO
2394
AIRO Group Holdings
AIRO
$265M
$16 ﹤0.01%
+2
New +$21
EVC icon
2395
Entravision Communication
EVC
$850M
$15 ﹤0.01%
+5
New +$15
SKIN icon
2396
SkinHealth Systems
SKIN
$91.1M
$15 ﹤0.01%
16
+7
+78% +$9
SLQT icon
2397
SelectQuote
SLQT
$122M
$15 ﹤0.01%
+23
New +$24
SNBR
2398
DELISTED
Sleep Number
SNBR
$15 ﹤0.01%
+8
New +$60
TBRG
2399
DELISTED
TruBridge
TBRG
$15 ﹤0.01%
+1
New +$19
AURA icon
2400
Aura Biosciences
AURA
$832M
$14 ﹤0.01%
+2
New +$11

Similar funds

SJS Investment Consulting's Q1 2026 Portfolio in Review

As of Q1 2026, SJS Investment Consulting held 2,597 positions worth $819M, up 3.6% from $790M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

SJS Investment Consulting deployed $39.9M of net new capital in Q1 2026, opening 508 new positions and adding to 1,194 existing holdings. Its largest new stake was Avantis Total Equity Markets ETF: 205,237 shares worth $9.65M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Apple, an estimated $1.32M trimmed.

  • SJS Investment Consulting's largest Q1 2026 buy was Avantis Total Equity Markets ETF: 205,237 shares worth $9.65M.
  • SJS Investment Consulting added most to Dimensional US Core Equity 2 ETF in Q1 2026, an estimated $4.83M increase.
  • SJS Investment Consulting's biggest Q1 2026 reduction was Apple, cutting an estimated $1.32M.
  • SJS Investment Consulting fully exited GeneDx Holdings in Q1 2026, selling an estimated $390K.
  • SJS Investment Consulting's ten largest holdings make up 73% of its $819M portfolio in Q1 2026.
  • SJS Investment Consulting opened 508 new positions and closed 123 in Q1 2026.
  • SJS Investment Consulting's portfolio value rose 3.6% quarter-over-quarter to $819M.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.